NCT01990859View on ClinicalTrials.gov

Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

February 28, 2015

Conditions
Melanoma
Interventions
BIOLOGICAL

Ipilimumab

Trial Locations (6)

1040045

Local Institution, Chuo-ku

3908621

Local Institution, Matsumoto-shi

4093898

Local Institution, Chuo-shi

4118777

Local Institution, Sunto-gun

8128582

Local Institution, Fukuoka

8608556

Local Institution, Kumamoto

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01990859 - Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients | Biotech Hunter | Biotech Hunter